Hisskof Oral Drops is a combination medication containing Levosalbutamol (0.25 mg/ml), Ambroxol (7.5 mg/ml), and Guaifenesin (12.5 mg/ml), formulated for the symptomatic relief of respiratory conditions associated with bronchospasm and excessive mucus production. Levosalbutamol, a selective β2-adrenergic receptor agonist, acts as a bronchodilator by relaxing the smooth muscles of the airways, thereby facilitating easier breathing in conditions such as asthma and chronic obstructive pulmonary disease (COPD). Ambroxol serves as a mucolytic agent, promoting the breakdown and clearance of viscous mucus from the respiratory tract, enhancing expectoration. Guaifenesin functions as an expectorant, increasing the hydration of respiratory tract secretions to reduce mucus viscosity and aid in its removal. The synergistic action of these active ingredients makes Hisskof Oral Drops effective in managing cough with thick mucus, bronchitis, and other respiratory tract infections where mucus congestion and airway constriction are prominent. It is recommended to be used under medical supervision, with dosage adjusted according to patient age and clinical condition. Caution is advised in patients with cardiovascular disorders, and potential side effects may include tremors, palpitations, or gastrointestinal disturbances.